|
Secondary prevention
Citations 51-60 of 110 total displayed.
|
Past content
(since Mar 1999):
|
- Original Articles
Valsartan, Blood Pressure Reduction, and C-Reactive Protein: Primary Report of the Val-MARC Trial
- Paul M Ridker, Eleanor Danielson, Nader Rifai, Robert J. Glynn for the Val-MARC Investigators
Hypertension 2006;48:73-79; published online before print as doi:10.1161/01.HYP.0000226046.58883.32
[Abstract]
[Full text]
- Scientific Contributions
Control of Hypertension 5 Years After Stroke in the North East Melbourne Stroke Incidence Study
- Seana L. Paul and Amanda G. Thrift
Hypertension published June 19, 2006, doi:10.1161/01.HYP.0000230610.81947.04
[Abstract]
- Scientific Contributions
Valsartan, Blood Pressure Reduction, and C-Reactive Protein. Primary Report of the Val-MARC Trial
- Paul M Ridker, Eleanor Danielson, Nader Rifai, Robert J. Glynn for the Val-MARC Investigators
Hypertension published May 19, 2006, doi:10.1161/01.HYP.0000226046.58883.32
[Abstract]
- Editorial Commentaries
Hypertension and the Treating Physician: Understanding and Reducing Therapeutic Inertia
- Lawrence J. Fine and Jeffrey A. Cutler
Hypertension 2006;47:319-320; published online before print as doi:10.1161/01.HYP.0000200692.23410.c9
[Full text]
- Editorial Commentaries
New Guidelines on Diet and Blood Pressure
- Thomas G. Pickering
Hypertension 2006;47:135-136; published online before print as doi:10.1161/01.HYP.0000202417.57909.26
[Full text]
- Editorial Commentary
Hypertension and the Treating Physician. Understanding and Reducing Therapeutic Inertia
- Lawrence J. Fine and Jeffrey A. Cutler
Hypertension published January 23, 2006, doi:10.1161/01.HYP.0000200692.23410.c9
[Abstract]
- Editorial Commentary
New Guidelines on Diet and Blood Pressure
- Thomas G. Pickering
Hypertension published January 9, 2006, doi:10.1161/01.HYP.0000202417.57909.26
[Abstract]
- Editorial Commentaries
More Evidence of Cardiorenal Protective Effects of Peroxisome Proliferator-Activated Receptor Activation
- Ernesto L. Schiffrin
Hypertension 2005;46:267-268; published online before print as doi:10.1161/01.HYP.0000172756.41375.e4
[Full text]
- Original Articles
Angiotensin-Converting Enzyme Inhibitors and Calcium Channel Blockers for Coronary Heart Disease and Stroke Prevention
- Paolo Verdecchia, Gianpaolo Reboldi, Fabio Angeli, Roberto Gattobigio, Maurizio Bentivoglio, Lutgarde Thijs, Jan A. Staessen, and Carlo Porcellati
Hypertension 2005;46:386-392; published online before print as doi:10.1161/01.HYP.0000174591.42889.a2
[Abstract]
[Full text]
- Scientific Contributions
Angiotensin-Converting Enzyme Inhibitors and Calcium Channel Blockers for Coronary Heart Disease and Stroke Prevention
- Paolo Verdecchia, Gianpaolo Reboldi, Fabio Angeli, Roberto Gattobigio, Maurizio Bentivoglio, Lutgarde Thijs, Jan A. Staessen, and Carlo Porcellati
Hypertension published July 11, 2005, doi:10.1161/01.HYP.0000174591.42889.a2
[Abstract]
|
|
